Alseres Pharmaceuticals, Inc. Reports License of Altropane® Worldwide Rights to Navidea Biopharmaceuticals, Inc. Conference Call to be Held Wednesday, August 1, 2012 at 11:00 a.m. Eastern...
HOPKINTON, Mass., May 7 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE; Alseres) announced today that effective on Friday, May 8, 2009 trading in its shares on the NASDAQ...
HOPKINTON, Mass., April 30 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE; the Company) announced today that on April 24, 2009 it entered into an Amendment to License...
HOPKINTON, Mass., Jan. 12 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. today announced that on January 8, 2009, it received notice from the NASDAQ Stock Market ("NASDAQ") that for the...
HOPKINTON, Mass., June 8 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSINASDAQ:andNASDAQ:ALSE) today announced that its proposed name change to Alseres Pharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
26 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
52 | 0 | 0 | 0.005 | 0.005 | 0.005 | 13 | 0.005 | CS |
156 | -0.005 | -50 | 0.01 | 0.01 | 0.005 | 10 | 0.00834171 | CS |
260 | -15.495 | -99.9677419355 | 15.5 | 15.5 | 0.005 | 14 | 6.33729196 | CS |
Symbol | Price | Vol. |
---|---|---|
RONNRonn Motor Group Inc (PK) | $ 0.0007 (-12.50%) | 125.58M |
GRLFGreen Leaf Innovations Inc (PK) | $ 0.0001 (0.00%) | 91.88M |
HMBLHUMBL Inc (PK) | $ 0.0002 (0.00%) | 47.07M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | $ 0.00275 (-5.17%) | 41.03M |
HCMCHealthier Choices Management Corporation (PK) | $ 0.000001 (-99.00%) | 35.95M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.